Octreotide Impurity 13 is an octreotide-related peptide characterized as a specific process or degradation product. Small differences in sequence or protecting-group history change its cyclization, ring conformation, and retention behavior. Researchers use it to establish impurity thresholds and validate analytical separation. Applications include QC profiling, process-development analysis, and structural-variant comparison.
CAT No: R2764
CAS No:1546983-33-8
Synonyms/Alias:(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-N-acetyl-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
Octreotide Impurity 13 is a specialized carbohydrate compound commonly encountered as a byproduct or degradation product in the synthesis and analysis of octreotide, a well-known peptide analog. Distinct in its structural configuration, Octreotide Impurity 13 plays a significant role in the comprehensive study of peptide synthesis pathways and impurity profiling. Its presence provides valuable insight into the stability, degradation mechanisms, and analytical challenges associated with complex peptide formulations. Researchers and analytical chemists rely on such impurity standards to ensure the integrity and reproducibility of their investigations, particularly when developing or refining methods for peptide purification and characterization. The unique molecular features of Octreotide Impurity 13 make it a critical reference point for advanced analytical techniques, offering a deeper understanding of the chemical landscape surrounding octreotide and related compounds.
Analytical Method Development: Octreotide Impurity 13 serves as an essential reference material in the development and validation of analytical methods for peptide-based pharmaceuticals. Its well-characterized structure enables laboratories to assess the sensitivity, specificity, and robustness of chromatographic and spectrometric techniques, such as HPLC and LC-MS. By incorporating this impurity into method validation protocols, scientists can accurately determine detection limits, quantify trace impurities, and optimize separation conditions, ultimately ensuring the reliability of routine quality control and research analyses.
Impurity Profiling and Characterization: The presence of Octreotide Impurity 13 is crucial for comprehensive impurity profiling during the manufacturing and storage of peptide drugs. By studying the formation and behavior of this impurity, researchers gain insights into degradation pathways, potential reaction intermediates, and the overall chemical stability of octreotide formulations. This information aids in identifying critical process parameters, mitigating unwanted side reactions, and designing more stable peptide products, thereby enhancing the overall understanding of peptide chemistry.
Reference Standard for Stability Studies: As a structurally defined impurity, Octreotide Impurity 13 is frequently employed as a reference standard in stability-indicating studies. Its inclusion allows researchers to monitor degradation trends over time and under various stress conditions, such as temperature, humidity, or light exposure. By accurately tracking the appearance and concentration of this impurity, scientists can better predict shelf-life, optimize storage conditions, and minimize the risk of product degradation, supporting robust stability protocols for peptide-based substances.
Process Optimization in Peptide Synthesis: Understanding the occurrence and control of Octreotide Impurity 13 is vital for the optimization of peptide synthesis processes. Chemists use it as a marker to evaluate the effectiveness of purification strategies, such as preparative HPLC or solid-phase extraction. Monitoring its levels throughout the synthetic workflow enables the identification of critical steps where impurity formation is most pronounced, facilitating the refinement of reaction conditions, purification methodologies, and overall yield improvement.
Peptide Degradation Mechanism Elucidation: Detailed study of Octreotide Impurity 13 provides valuable mechanistic insights into the degradation and transformation pathways of peptide molecules. By isolating and characterizing this impurity, researchers can investigate the chemical reactions responsible for its formation, such as hydrolysis, oxidation, or rearrangement. These findings contribute to a broader understanding of peptide stability, inform the design of more robust analogs, and support the development of predictive models for impurity formation during manufacturing and storage.
In summary, Octreotide Impurity 13 is indispensable across a spectrum of scientific and industrial applications, including analytical method development, impurity profiling, stability studies, process optimization, and mechanistic research. Its unique role as a structurally characterized impurity standard not only enhances the accuracy and reliability of analytical assays but also deepens our understanding of peptide chemistry and degradation. By leveraging its properties and analytical value, researchers and process chemists can achieve higher standards of quality, reproducibility, and innovation in the field of peptide research and manufacturing.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.